Identifying Acute STEMI in the Presence of Paced Rhythm
EMS responds to a local coffee shop for a 77-year-old male who has reportedly fainted. While en route the call is upgraded to an unconscious patient and an engine company is dispatched for backup. On arrival the patient is conscious but lethargic. He appears acutely ill. The skin is pale and diaphoretic. His past medical history includes hypertension, dyslipidemia, myocardial infarction, a coronary artery bypass graft and heart failure. His current medications are aspirin, metoprolol, atorvastatin, lisinopril and furosemide. Upon further questioning he admits to chest discomfort. His OPQRST assessment is as follows: ≫ On...
Source: JEMS Special Topics - January 18, 2016 Category: Emergency Medicine Authors: Tom Bouthillet, NREMT-P Tags: Case of the Month Special Topics Cardiac & Resuscitation Patient Care Source Type: news

Identifying Acute STEMI in the Presence of Paced Rhythm
EMS responds to a local coffee shop for a 77-year-old male who has reportedly fainted. While en route the call is upgraded to an unconscious patient and an engine company is dispatched for backup. On arrival the patient is conscious but lethargic. He appears acutely ill. The skin is pale and diaphoretic. His past medical history includes hypertension, dyslipidemia, myocardial infarction, a coronary artery bypass graft and heart failure. His current medications are aspirin, metoprolol, atorvastatin, lisinopril and furosemide. Upon further questioning he admits to chest discomfort. His OPQRST assessment is as follows: ≫ On...
Source: JEMS Patient Care - January 18, 2016 Category: Emergency Medicine Authors: Tom Bouthillet, NREMT-P Tags: Case of the Month Special Topics Cardiac & Resuscitation Patient Care Source Type: news

Identifying Acute STEMI in the Presence of Paced Rhythm
EMS responds to a local coffee shop for a 77-year-old male who has reportedly fainted. While en route the call is upgraded to an unconscious patient and an engine company is dispatched for backup. On arrival the patient is conscious but lethargic. He appears acutely ill. The skin is pale and diaphoretic. His past medical history includes hypertension, dyslipidemia, myocardial infarction, a coronary artery bypass graft and heart failure. His current medications are aspirin, metoprolol, atorvastatin, lisinopril and furosemide. Upon further questioning he admits to chest discomfort. His OPQRST assessment is as follows: ≫ On...
Source: JEMS Special Topics - January 18, 2016 Category: Emergency Medicine Authors: Tom Bouthillet, NREMT-P Tags: Cardiac & Resuscitation Special Topics Patient Care Source Type: news

Metoprolol Injection (Updated - Currently in Shortage)
Updated Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - January 5, 2016 Category: Drugs & Pharmacology Source Type: news

Lopressor Injection (Metoprolol Tartrate Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 21, 2015 Category: Drugs & Pharmacology Source Type: news

Candesartan May Cut Cardiotoxicity in Breast Cancer PatientsCandesartan May Cut Cardiotoxicity in Breast Cancer Patients
Adjuvant candesartan (but not metoprolol) showed "significant but modest" attenuation of LVEF changes after cancer therapy. More research is needed, but "this study is a key first step," notes one expert. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 12, 2015 Category: Cardiology Tags: Cardiology News Source Type: news

AHA: Candesartan May Preserve Cardiac Function in Breast Ca Patients
(MedPage Today) -- But no difference seen with beta-blocker metoprolol (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - November 11, 2015 Category: Primary Care Source Type: news

Diltiazem vs Metoprolol for AF With Rapid Ventricular RateDiltiazem vs Metoprolol for AF With Rapid Ventricular Rate
Which of these agents is more effective for the ED management of atrial fibrillation and flutter? A new study compares the efficacy. The Journal of Emergency Medicine (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - September 16, 2015 Category: Emergency Medicine Tags: Emergency Medicine Journal Article Source Type: news

Podcast: Managing the crashing tox patient with ECMO
As I wrote about in a recent column for Emergency Medicine News, extracorporeal membrane oxygenation (ECMO) may be the next big thing in managing the severely ill, crashing overdose patient in whom usual therapy is not working. On the new podcast posted today at the EDECMO website, Steve Aks and I got together over Skype with Joe Bellezzo, Zack Shinar, and Scott Weingart to discuss the potential benefits, as well as the potential risks and complications, involved in using ECMO in the sickest tox patients. Some of the topics we discuss: What overdose patients might benefit most from ECMO? What vascular access is needed fo...
Source: The Poison Review - June 16, 2015 Category: Toxicology Authors: Leon Tags: Medical ECMO edecmo extracorporeal membrane oxygenation podcast poisoning toxicology Source Type: news

Excellent review of lipid rescue therapy
3.5 out of 5 stars Intravenous Lipid Emulsion in the Emergency Department: A Systematic Review of Recent Literature. Cao D et al. J Emerg Med 2014 Dec 19 [Epub ahead of print] Abstract This excellent comprehensive review of lipid rescue therapy (LRT) is vitiated only by the unavoidable fact that available clinical evidence  is so inconclusive. As the authors point out, published literature consists mostly of case reports and small case series. The vast majority of these reported cases have good outcomes and reflect positive effects from ILE, but the evidence is marred by multiple confounding variables (such as concurren...
Source: The Poison Review - February 25, 2015 Category: Toxicology Authors: Leon Tags: Medical intralipid lipid emulsion lipid rescue therapy lipid sink Review Source Type: news

FDA Recalls Another Batch of Generic Metoprolol (FREE)
By Larry Husten Edited by David G. Fairchild, MD, MPH, and Richard Saitz, MD, MPH, FACP, FASAM The FDA has recalled more than 13,000 bottles of metoprolol succinate extended-release tablets manufactured by Dr. Reddy's Laboratories, Reuters reported late last … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 25, 2014 Category: Primary Care Source Type: news

FDA Recalls Another Batch Of Generic Metoprolol
The FDA has recalled more than 13,000 bottles of metoprolol succinate extended release tablets manufactured by Dr. Reddy's Laboratories. Two months ago the agency recalled another lot of generic metoprolol from a different company, Wockhardt. Both recalls were for medicines manufactured at facilities in India. There have been multiple reports in recent years of problems with generic drugs made in India. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 24, 2014 Category: Pharmaceuticals Authors: Larry Husten Source Type: news